Akribion Therapeutics emerges from stealth with €8 million in seed funding to develop a novel cancer RNA-guided approach ...

New discovery reveals an entire new world smaller than viruses and bacteria.

FROM weather forecast, healthcare, agriculture, science discovery to education, Alibaba’s AI Innovations aim to bring ...

Norovirus cases increased in prevalence throughout the Washington, D.C., metropolitan area during winter months, prompting Georgetown University students to prioritize health on campus. Norovirus is ...

A recent study published in Nature Communications by researchers at the National Institute of Allergy and Infectious Diseases (NIAID) and collaborators evaluated a replicating RNA (repRNA) vaccine ...

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to brelovitug (BJT-778) for the treatment of chronic hepatitis delta (CHD).

Discover how scientists developed a COVID-19 vaccine in record time using mRNA technology, leading to improved public health ...

Researchers at the University of Queensland identified Camp Hill virus, a type of henipavirus, in shrews in Alabama. This ...

Ethris announces promising phase 1 results for ETH47, its mRNA therapy for uncontrolled asthma. The inhaled treatment showed strong safety and efficacy, with plans for a phase 2 trial in 2025.

Fintel reports that on January 28, 2025, BTIG initiated coverage of Arcturus Therapeutics Holdings (NasdaqGM:ARCT) with a Buy ...

It started as a respiratory illness—or so everyone thought. But it quickly became apparent that SARS-CoV-2, the virus that ...